Fusidic acid resistance in Staphylococcus aureus isolates.
about
Interventions to reduce Staphylococcus aureus in the management of atopic eczemaMechanism of Elongation Factor-G-mediated Fusidic Acid Resistance and Fitness Compensation in Staphylococcus aureusCharacterization of community-associated Staphylococcus aureus from skin and soft-tissue infections: a multicenter study in ChinaFusidic acid cream for impetigo. Fusidic acid should be used with restraint.Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.Nadifloxacin: a quinolone for topical treatment of skin infections and potential for systemic use of its active isomer, WCK 771.Fusidic acid resistance in Staphylococcus aureus.Antibiotic Susceptibility of Staphylococcus aureus in Atopic Dermatitis: Current Prevalence of Methicillin-Resistant Staphylococcus aureus in Korea and Treatment StrategiesComparison of Disk Diffusion and Etest Methods to Determine the Susceptibility of Staphylococcus aureus Circulating in Riyadh, Saudi Arabia to Fusidic Acid.A guide to antibiotic resistance in bacterial skin infections.Predicting bacterial cause in infectious conjunctivitis: cohort study on informativeness of combinations of signs and symptomsIn vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates.Susceptibility in vitro of canine methicillin-resistant and -susceptible staphylococcal isolates to fusidic acid, chlorhexidine and miconazole: opportunities for topical therapy of canine superficial pyoderma.Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid.Evidence of Bacterial Biofilms among Infected and Hypertrophied Tonsils in Correlation with the Microbiology, Histopathology, and Clinical Symptoms of Tonsillar Diseases.Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus.In vitro activity of CEM-102 (fusidic acid) against prevalent clones and resistant phenotypes of Staphylococcus aureus.Compensatory adaptation to the loss of biological fitness associated with acquisition of fusidic acid resistance in Staphylococcus aureus.Mutations in fusA associated with posttherapy fusidic acid resistance in Clostridium difficile.A target-protection mechanism of antibiotic resistance at atomic resolution: insights into FusB-type fusidic acid resistance.Clonal spread among Swedish children of a Staphylococcus aureus strain resistant to fusidic acid.Povidone-iodine ointment demonstrates in vitro efficacy against biofilm formation.Molecular basis of fusB-mediated resistance to fusidic acid in Staphylococcus aureus.Impetigo: A need for new therapies in a world of increasing antimicrobial resistance.The silver cation (Ag+): antistaphylococcal activity, mode of action and resistance studies.Staphylococcus aureusand topical fusidic acid use: results of a clinical audit on antimicrobial resistance
P2860
Q24242048-CD06ABBF-535E-467D-88C8-4F83EF4EB2C5Q27670650-BF8CB530-5A9F-455B-A04E-BFE4FDFEA632Q28354183-1E9AB0A8-DDB6-4878-BE25-AE968D1BD19FQ33810771-31D830B6-FA18-4FD9-9DF5-E3DDF1081B9BQ34481625-C38D9BB8-B3D8-4DAE-A448-77FE769C9B96Q34571545-89BCC0DE-96EC-41D0-A949-39BD90BF072BQ35622199-12F4D672-6C6B-4237-A322-758E2FD4B4D8Q35931908-D00364AF-9E38-4061-9C9C-5029BA02C928Q36131833-39B9CBF9-6A7D-45C1-9B73-8A2B9D8BB861Q36258130-96751E99-D483-43B6-A448-670437DA3D84Q36927885-98C879EF-76AA-4B90-BBEE-3F64028C0C8FQ39833267-6B1EFFF6-3B20-4264-B196-F9E35523C994Q39955761-1DC83E99-7266-422A-BE25-D62A983442E8Q41444416-415B6063-DF58-4458-8E56-769939C0D4D7Q41833887-D4934EC4-9ED5-4E53-AD70-E8FD4DB227F4Q41861992-7F68216F-6573-4EAD-A1B1-7B2D39C0F8A6Q41991408-E0A50CAD-C3E6-4688-A83E-CE473F7D651EQ42139264-82A3D7B0-53EF-421C-A300-C66B91916169Q42708789-CB0392EE-24E9-4D65-A033-E8A3232E8F34Q42845938-9860A26D-BBB3-4735-8A01-9C1FD3A0DE03Q43069439-F13CD48D-DCFA-4F68-9EF2-C0F993DB33BFQ44245700-A2CE91B1-D5F2-44E0-A5BE-D74E5BED8BF3Q46581311-6442631D-B3B4-4881-8B58-BDB8FDB67AFAQ46877406-B186E359-9164-4157-8FAE-9F6F25913E25Q47880316-A98BD902-E570-4853-B71C-BAF97DC21C66Q52842534-B6450B04-2469-4B1D-A86D-717247DEA192Q56880967-6A72B325-097F-44C3-B14E-58FF5DFD650F
P2860
Fusidic acid resistance in Staphylococcus aureus isolates.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Fusidic acid resistance in Staphylococcus aureus isolates.
@en
Fusidic acid resistance in Staphylococcus aureus isolates.
@nl
type
label
Fusidic acid resistance in Staphylococcus aureus isolates.
@en
Fusidic acid resistance in Staphylococcus aureus isolates.
@nl
prefLabel
Fusidic acid resistance in Staphylococcus aureus isolates.
@en
Fusidic acid resistance in Staphylococcus aureus isolates.
@nl
P1433
P1476
Fusidic acid resistance in Staphylococcus aureus isolates.
@en
P2093
Erwin M Brown
Paul Thomas
P356
10.1016/S0140-6736(02)07869-8
P407
P577
2002-03-01T00:00:00Z